Patents Assigned to Carter-Wallace, Inc.
  • Patent number: 6964959
    Abstract: The invention provides a method of inhibiting tumor growth in a mammal, by administering to the mammal composition containing methylol-containing compound. The composition is administered to directly contact a tumor cell at a dose sufficient to induce cell death by apoptosis.
    Type: Grant
    Filed: December 6, 2000
    Date of Patent: November 15, 2005
    Assignees: Carter Wallace, Inc., Rhode Island Hospital
    Inventors: Paul Calabresi, James Darnowski, James Costin
  • Publication number: 20030044461
    Abstract: Compositions consisting essentially of carbetapentane tannate and guaifenesin which are effective when administered orally for the symptomatic relief of cough associated with respiratory tract conditions such as the common cold, bronchial asthma, acute and chronic bronchitis are disclosed.
    Type: Application
    Filed: August 22, 2001
    Publication date: March 6, 2003
    Applicant: Carter-Wallace, Inc.
    Inventors: Phuong Grace Dang, Alexander D. D'Addio
  • Patent number: 6523540
    Abstract: The present invention relates to improved condoms which in addition to providing protection against the transmission of disease and pregnancy also allow for a high degree of stimulation and sensitivity during sexual intercourse. The condoms comprise thin, soft, strong polyether polyol and polyester polyol diisocyanate based polyurethane elastomers in combination with a spermicidal lubricant.
    Type: Grant
    Filed: March 12, 1999
    Date of Patent: February 25, 2003
    Assignee: Carter-Wallace, Inc.
    Inventor: Michael J. Harrison
  • Publication number: 20020099021
    Abstract: Tannate compositions consisting essentially of carbetapentane tannate and chlorpheniramine tannate which are effective when administered orally for the symptomatic relief of coryza associated with the common cold, sinusitis, allergic rhinitis, unproductive cough and upper respiratory tract conditions are disclosed.
    Type: Application
    Filed: November 30, 2000
    Publication date: July 25, 2002
    Applicant: Carter-Wallace, Inc.
    Inventors: Ronald J. Leflein, Alexander D. D'Addio
  • Patent number: 6350742
    Abstract: The use of 4,4-methylenebis(tetrahydro-1,2,4-thiadiazine-1,2-dioxide) in treating infections of the ear.
    Type: Grant
    Filed: March 10, 1999
    Date of Patent: February 26, 2002
    Assignee: Carter-Wallace, Inc.
    Inventor: James C. Costin
  • Patent number: 6321751
    Abstract: A condom includes a plurality of intersecting spiral ribs extending in two different directional planes along at least a portion of the surface between the open and closed ends of the condom, with each rib being oriented at an angle of about 15° to the transverse axis of the condom.
    Type: Grant
    Filed: March 22, 2000
    Date of Patent: November 27, 2001
    Assignee: Carter-Wallace, Inc.
    Inventors: Steven R. Strauss, Richard D. Kline, Jim D. Burns, Michael J. Harrison
  • Patent number: 6319676
    Abstract: The invention provides an improved test cell for detecting the presence of an analyte in a liquid sample. The device has an elongate casing defining a liquid sample inlet, a reservoir volume, a test volume, and a window through the casing at the test volume. Disposed within the cell is a sample absorbent, a novel biphasic substrate and a reservoir, together capable of transporting an aqueous solution within the casing along a flow path extending from the sample inlet through the test volume and into the reservoir volume. The invention further comprises a method for detecting the presence of an analyte in a liquid sample using the device and a biphasic chromatographic material for carrying out the method.
    Type: Grant
    Filed: May 2, 1995
    Date of Patent: November 20, 2001
    Assignee: Carter Wallace, Inc.
    Inventors: Albert Nazareth, Mary Beth Boyle, Yea-Shun Cheng
  • Patent number: 6308708
    Abstract: A condom includes a plurality of intersecting spiral ribs extending in two different directional planes along at least a portion of the surface between the open and closed ends of the condom, with each rib being oriented at an angle of about 15° to the transverse axis of the condom.
    Type: Grant
    Filed: May 21, 2001
    Date of Patent: October 30, 2001
    Assignee: Carter-Wallace, Inc.
    Inventors: Steven R. Strauss, Richard D. Kline, Jim D. Burns, Michael J. Harrison
  • Patent number: 6306904
    Abstract: Tannate compositions consisting essentially of carbetapentane tannate and pyrilamine tannate which are effective when administered orally for the symptomatic relief of coryza associated with the common cold, sinusitis, allergic rhinitis, unproductive cough and upper respiratory tract conditions are disclosed.
    Type: Grant
    Filed: July 25, 2000
    Date of Patent: October 23, 2001
    Assignee: Carter-Wallace, Inc.
    Inventor: Steven A. Gordziel
  • Patent number: 6302108
    Abstract: There is provided spermicidal/antiviral compositions in the form of lotions, cremes, foams and gels that are non-irritating. The compositions contain an effective amount of 4,4′-methylenebis-(tetrahydro-1,2,4-thiadiazine)-1,1,1′,1′-tetraoxide as a spermicide/virucide.
    Type: Grant
    Filed: March 10, 2000
    Date of Patent: October 16, 2001
    Assignee: Carter-Wallace, Inc
    Inventor: Ralph Levine
  • Patent number: 6287597
    Abstract: Tannate compositions consisting essentially of pyrilamine tannate and phenylephrine tannate which are effective when administered orally for the symptomatic relief of coryza associated with the common cold, sinusitis, allergic rhinitis and upper respiratory tract conditions are disclosed.
    Type: Grant
    Filed: March 12, 1999
    Date of Patent: September 11, 2001
    Assignee: Carter-Wallace, Inc.
    Inventor: Steven A. Gordziel
  • Patent number: 6277650
    Abstract: The invention is an improved single-step test device for detecting the presence of a pre-selected analyte in a urine stream. The device includes a hollow rectangular outer casing and an assay material disposed within co-joined upper and lower sections of the casing. The outer casing includes a urine inlet port; a viewing window in the upper section; at least the upper section consisting of transparent material; and may also include at least one drainage vent spaced about the urine inlet port. The assay material is a sorptive material including: a urine sample application region adjacent to, and in fluid communication with the urine inlet port; a capture region adjacent to the viewing window; and a fluid flow path for transporting a liquid sample between the urine sample application region and the analyte capture region. The flow of urine in the fluid path is observable through the transparent upper section for confirming a test is operative.
    Type: Grant
    Filed: December 31, 1998
    Date of Patent: August 21, 2001
    Assignee: Carter-Wallace, Inc.
    Inventors: Albert R. Nazareth, Mary Beth Boyle, Yea-Shun Cheng
  • Patent number: 6273702
    Abstract: Prophylactic devices are made in an inert atmosphere by cooling mandrels on which the devices are to be deposited, dipping the mandrels into a polymeric material in a solvent/carrier and a mold release agent, rotating the mandrels during and after the dipping, and evaporating the solvent after dipping. The apparatus includes an air lock between a section in which these functions are performed and a section located in an air atmosphere for removing the devices from the mandrels, followed by cleaning the mandrels for use in a subsequent production run for making devices.
    Type: Grant
    Filed: September 21, 1999
    Date of Patent: August 14, 2001
    Assignee: Carter-Wallace, Inc.
    Inventor: Frederick P. Sisbarro
  • Patent number: 6251896
    Abstract: The present invention relates to a method of treating a human infected with Crohn's disease comprising enterally administering to the individual in need of such treatment an effective amount of a composition comprising 4,4′-methylenebis-(tetrahydro-1,2,4-thiadiazine)-1,1,1′,1′-tetraoxide, commonly known as taurolidine.
    Type: Grant
    Filed: March 24, 2000
    Date of Patent: June 26, 2001
    Assignee: Carter-Wallace, Inc.
    Inventor: James C. Costin
  • Patent number: 6231326
    Abstract: Prophylactic devices are made in an inert atmosphere by cooling mandrels on which the devices are to be deposited, dipping the mandrels into a polymeric material in a solvent/carrier and a mold release agent, rotating the mandrels during and after the dipping, and evaporating the solvent after dipping. The apparatus includes an air lock between a section in which these functions are performed and a section located in an air atmosphere for removing the devices from the mandrels, followed by cleaning the mandrels for use in a subsequent production run for making devices.
    Type: Grant
    Filed: September 21, 1999
    Date of Patent: May 15, 2001
    Assignee: Carter-Wallace, Inc.
    Inventor: Frederick P. Sisbarro
  • Patent number: 6217815
    Abstract: Prophylactic devices are made in an inert atmosphere by cooling mandrels on which the devices are to be deposited, dipping the mandrels into a polymeric material in a solvent/carrier and a mold release agent, rotating the mandrels during and after the dipping, and evaporating the solvent after dipping. The apparatus includes an air lock between a section in which these functions are performed and a section located in an air atmosphere for removing the devices from the mandrels, followed by cleaning the mandrels for use in a subsequent production run for making devices.
    Type: Grant
    Filed: June 10, 1998
    Date of Patent: April 17, 2001
    Assignee: Carter-Wallace, Inc.
    Inventor: Frederick P. Sisbarro
  • Patent number: 6190155
    Abstract: A pair of opposing shoes are alternately and successively moved into and out of contact with a ring previously formed on a prophylactic device on a mandrel, whereby the mandrel or the shoes or both are moved in a direction during each time of contact of the shoes with the rolled portion of the device, for at least partially rolling the prophylactic device up toward its closed end, with the process being repeated until the prophylactic device is rolled up and off of the mandrel.
    Type: Grant
    Filed: September 21, 1999
    Date of Patent: February 20, 2001
    Assignee: Carter-Wallace, Inc.
    Inventors: Frederick P. Sisbarro, Harry G. Hawk
  • Patent number: 6164122
    Abstract: A plurality of test chambers or fixtures are operable for successively testing a plurality of condoms, respectively, in an automated manner. Each test chamber for testing a condom includes a housing containing a porous liner having an interior cavity conformed to the exterior shape of a condom to be tested, whereby a holder carrying the condom is inserted into the liner, a closed pathway for gas flow is provided between a gas port of the holder and the interior volume of the condom, for permitting the condom to be inflated with the gas, causing the exterior walls of the condom to be pushed against opposing inside walls of the liner, permitting gas passing through holes in the condom to flow through pores in walls of the liner to another gas port of the housing for detecting unacceptable holes in the condom using differential pressure techniques and/or gas tagging.
    Type: Grant
    Filed: April 21, 1999
    Date of Patent: December 26, 2000
    Assignee: Carter-Wallace, Inc.
    Inventors: Frederick P. Sisbarro, Glenn W. Thomsen
  • Patent number: D439969
    Type: Grant
    Filed: March 22, 2000
    Date of Patent: April 3, 2001
    Assignee: Carter-Wallace, Inc.
    Inventors: Steven R. Strauss, Richard D. Kline, Jim D. Burns, Michael J. Harrison
  • Patent number: D447419
    Type: Grant
    Filed: May 23, 2000
    Date of Patent: September 4, 2001
    Assignee: Carter-Wallace, Inc.
    Inventor: Ronald J. Jaketic